Home LiteratureArticle Details
PMID: 18951640 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Mutant huntingtin and mitochondrial dysfunction.

Trends in neurosciences ·Vol. 31 ·No. 12 ·2008-12-00 ·Pages 609-16

Bossy-Wetzel E, Petrilli A, Knott AB

Abstract

Huntington's disease (HD) is a fatal, inherited neurodegenerative disorder that gradually robs affected individuals of memory, cognitive skills and normal movements. Although research has identified a single faulty gene, the huntingtin gene, as the cause of the disease, a cure remains elusive. Strong evidence indicates that mitochondrial impairment plays a key part in HD pathogenesis. Here, we highlight how mutant huntingtin (mtHtt) might cause mitochondrial dysfunction by either perturbing transcription of nuclear-encoded mitochondrial proteins or by direct interaction with the organelle and modulation of respiration, mitochondrial membrane potential and Ca(2+) buffering. In addition, we propose that mtHtt might convey its neurotoxicity by evoking defects in mitochondrial dynamics, organelle trafficking and fission and fusion, which, in turn, might result in bioenergetic failure and HD-linked neuronal dysfunction and cell death. Finally, we speculate how mitochondria might dictate selective vulnerability of long projection neurons, such as medium spiny neurons, which are particularly affected in HD.

MeSH Terms
Animals Humans Huntingtin Protein Mitochondria/pathology,physiology Mitochondrial Diseases/genetics Models, Biological Mutation Nerve Tissue Proteins/genetics Nuclear Proteins/genetics
Chemicals
HTT protein, human Huntingtin Protein Nerve Tissue Proteins Nuclear Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bossy-Wetzel Ella
University of Central Florida, Burnett School of Biomedical Sciences, College of Medicine, 4000 Central Florida Boulevard, Orlando, FL 32816, USA. ebossywe@mail.ucf.edu
Petrilli Alejandra
Knott Andrew B
References (118)
118 references, click to expand
  1. Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating.
    Neuron. 2003 Nov 13;40(4):733-48 PMID: 14622578
  2. Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin.
    Neuron. 2003 Nov 13;40(4):749-62 PMID: 14622579
  3. Cell death: critical control points.
    Cell. 2004 Jan 23;116(2):205-19 PMID: 14744432
  4. Mitochondrial dysfunction as a cause of optic neuropathies.
    Prog Retin Eye Res. 2004 Jan;23(1):53-89 PMID: 14766317
  5. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.
    Mol Cell Neurosci. 2004 Mar;25(3):469-79 PMID: 15033175
  6. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Trends Genet. 2004 Mar;20(3):146-54 PMID: 15036808
  7. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.
    Nat Genet. 2004 May;36(5):449-51 PMID: 15064763
  8. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
    Hum Mol Genet. 2004 Jul 15;13(14):1407-20 PMID: 15163634
  9. Huntington's disease: new paths to pathogenesis.
    Cell. 2004 Jul 9;118(1):4-7 PMID: 15242639
  10. Role of Bax and Bak in mitochondrial morphogenesis.
    Nature. 2006 Oct 12;443(7112):658-62 PMID: 17035996
  11. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
    Nature. 2006 Oct 19;443(7113):787-95 PMID: 17051205
  12. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.
    Cell. 2006 Oct 20;127(2):397-408 PMID: 17055439
  13. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
    Cell Metab. 2006 Nov;4(5):349-62 PMID: 17055784
  14. Striatal specificity of gene expression dysregulation in Huntington's disease.
    J Neurosci Res. 2006 Nov 1;84(6):1151-64 PMID: 16983659
  15. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
    Cell Mol Life Sci. 2006 Nov;63(22):2642-60 PMID: 17041811
  16. Apoptosome: a platform for the activation of initiator caspases.
    Cell Death Differ. 2007 Jan;14(1):56-65 PMID: 16977332
  17. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.
    Hum Mol Genet. 2007 Jan 1;16(1):61-77 PMID: 17135277
  18. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
    J Neurosci. 2007 Jan 10;27(2):422-30 PMID: 17215403
  19. Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space.
    Hum Mol Genet. 2007 Feb 15;16(4):391-409 PMID: 17189290
  20. Functional consequences of mitochondrial proteome heterogeneity.
    Am J Physiol Cell Physiol. 2007 Feb;292(2):C698-707 PMID: 16971502
  21. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.
    Prog Neurobiol. 2007 Apr;81(5-6):272-93 PMID: 17188796
  22. New insights into mitochondrial fusion.
    FEBS Lett. 2007 May 22;581(11):2168-73 PMID: 17331506
  23. Huntingtin facilitates dynein/dynactin-mediated vesicle transport.
    Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10045-50 PMID: 17548833
  24. The machines that divide and fuse mitochondria.
    Annu Rev Biochem. 2007;76:751-80 PMID: 17362197
  25. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.
    Hum Mol Genet. 2007 Nov 1;16(21):2600-15 PMID: 17704510
  26. Functions and dysfunctions of mitochondrial dynamics.
    Nat Rev Mol Cell Biol. 2007 Nov;8(11):870-9 PMID: 17928812
  27. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.
    J Neurosci. 2007 Dec 12;27(50):13614-23 PMID: 18077673
  28. Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!
    Cell Mol Neurobiol. 2007 Nov;27(7):867-75 PMID: 17952586
  29. The BCL-2 protein family: opposing activities that mediate cell death.
    Nat Rev Mol Cell Biol. 2008 Jan;9(1):47-59 PMID: 18097445
  30. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons.
    Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2169-74 PMID: 18250306
  31. Mitochondrial fragmentation in neurodegeneration.
    Nat Rev Neurosci. 2008 Jul;9(7):505-18 PMID: 18568013
  32. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons.
    EMBO J. 2008 Aug 6;27(15):2124-34 PMID: 18615096
  33. Calcium ions in neuronal degeneration.
    IUBMB Life. 2008 Sep;60(9):575-90 PMID: 18478527
  34. Mitochondria and neuronal survival.
    Physiol Rev. 2000 Jan;80(1):315-60 PMID: 10617771
  35. Wild-type huntingtin protects from apoptosis upstream of caspase-3.
    J Neurosci. 2000 May 15;20(10):3705-13 PMID: 10804212
  36. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
    Hum Mol Genet. 2000 May 22;9(9):1259-71 PMID: 10814708
  37. Transcriptional dysregulation in Huntington's disease.
    Trends Neurosci. 2000 Sep;23(9):387-92 PMID: 10941183
  38. Cyclin-dependent kinases as a therapeutic target for stroke.
    Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10254-9 PMID: 10944192
  39. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.
    Nat Genet. 2000 Sep;26(1):29-36 PMID: 10973244
  40. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.
    Nat Genet. 2000 Oct;26(2):207-10 PMID: 11017079
  41. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.
    Nat Genet. 2000 Oct;26(2):211-5 PMID: 11017080
  42. Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo.
    Am J Hum Genet. 2001 Feb;68(2):313-24 PMID: 11133364
  43. SH3GLB, a new endophilin-related protein family featuring an SH3 domain.
    Genomics. 2001 Jan 15;71(2):222-34 PMID: 11161816
  44. Loss of normal huntingtin function: new developments in Huntington's disease research.
    Trends Neurosci. 2001 Mar;24(3):182-8 PMID: 11182459
  45. Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax.
    J Biol Chem. 2001 Jun 8;276(23):20559-65 PMID: 11259440
  46. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
    Science. 2001 Jul 20;293(5529):493-8 PMID: 11408619
  47. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells.
    Mol Biol Cell. 2001 Aug;12(8):2245-56 PMID: 11514614
  48. Juvenile onset Huntington's disease--clinical and research perspectives.
    Ment Retard Dev Disabil Res Rev. 2001;7(3):153-7 PMID: 11553930
  49. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
    Cell. 1997 Aug 8;90(3):537-48 PMID: 9267033
  50. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    Science. 1997 Sep 26;277(5334):1990-3 PMID: 9302293
  51. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.
    EMBO J. 1998 Jan 2;17(1):37-49 PMID: 9427739
  52. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells.
    Nature. 2007 May 24;447(7143):447-52 PMID: 17450122
  53. Huntingtin interacting proteins are genetic modifiers of neurodegeneration.
    PLoS Genet. 2007 May 11;3(5):e82 PMID: 17500595
  54. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Arch Neurol. 2007 Jun;64(6):813-9 PMID: 17562929
  55. Mammalian dynamin-like protein DLP1 tubulates membranes.
    Mol Biol Cell. 2001 Sep;12(9):2894-905 PMID: 11553726
  56. Modeling Huntington's disease in cells, flies, and mice.
    Mol Neurobiol. 2001 Feb;23(1):21-51 PMID: 11642542
  57. The expanding role of mitochondria in apoptosis.
    Genes Dev. 2001 Nov 15;15(22):2922-33 PMID: 11711427
  58. Hip1 and Hippi participate in a novel cell death-signaling pathway.
    Dev Cell. 2002 Feb;2(2):126-8 PMID: 11832235
  59. Interaction of Huntington disease protein with transcriptional activator Sp1.
    Mol Cell Biol. 2002 Mar;22(5):1277-87 PMID: 11839795
  60. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription.
    J Biol Chem. 2002 Mar 1;277(9):7466-76 PMID: 11739372
  61. Regional and progressive thinning of the cortical ribbon in Huntington's disease.
    Neurology. 2002 Mar 12;58(5):695-701 PMID: 11889230
  62. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
    Neuron. 2002 Mar 14;33(6):849-60 PMID: 11906693
  63. Lessons from animal models of Huntington's disease.
    Trends Genet. 2002 Apr;18(4):202-9 PMID: 11932021
  64. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
    Science. 2002 Jun 21;296(5576):2238-43 PMID: 11988536
  65. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.
    FEBS Lett. 2002 Jul 17;523(1-3):171-6 PMID: 12123827
  66. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
    Cell. 2004 Jul 9;118(1):127-38 PMID: 15242649
  67. Relationships between superoxide levels and delayed calcium deregulation in cultured cerebellar granule cells exposed continuously to glutamate.
    J Neurochem. 2004 Aug;90(3):683-93 PMID: 15255947
  68. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1.
    J Cell Sci. 2004 Sep 1;117(Pt 19):4389-400 PMID: 15304525
  69. Deranged neuronal calcium signaling and Huntington disease.
    Biochem Biophys Res Commun. 2004 Oct 1;322(4):1310-7 PMID: 15336977
  70. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.
    Mol Cell Biol. 2004 Sep;24(18):8195-209 PMID: 15340079
  71. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice.
    Cell. 2004 Oct 1;119(1):121-35 PMID: 15454086
  72. Nutritional evaluation of Huntington disease patients.
    Am J Clin Nutr. 1989 Jul;50(1):145-50 PMID: 2526577
  73. Excitotoxic injury of the neostriatum: a model for Huntington's disease.
    Trends Neurosci. 1990 Jul;13(7):286-9 PMID: 1695405
  74. Identification of an Alu retrotransposition event in close proximity to a strong candidate gene for Huntington's disease.
    Nature. 1993 Mar 25;362(6418):370-3 PMID: 8384324
  75. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
    Cell. 1993 Mar 26;72(6):971-83 PMID: 8458085
  76. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients.
    Neurology. 1995 Oct;45(10):1879-83 PMID: 7477986
  77. HEAT repeats in the Huntington's disease protein.
    Nat Genet. 1995 Oct;11(2):115-6 PMID: 7550332
  78. Mitochondrial defect in Huntington's disease caudate nucleus.
    Ann Neurol. 1996 Mar;39(3):385-9 PMID: 8602759
  79. Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.
    Curr Opin Neurol. 1995 Dec;8(6):469-73 PMID: 8845934
  80. Mitochondria and apoptosis.
    Science. 1998 Aug 28;281(5381):1309-12 PMID: 9721092
  81. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.
    J Neuropathol Exp Neurol. 1999 Feb;58(2):165-73 PMID: 10029099
  82. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state.
    J Biol Chem. 1999 Mar 5;274(10):6080-4 PMID: 10037689
  83. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity.
    J Cell Sci. 2004 Dec 15;117(Pt 26):6535-46 PMID: 15572413
  84. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.
    Hum Genet. 2005 Jan;116(1-2):23-7 PMID: 15549395
  85. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.
    Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2602-7 PMID: 15695335
  86. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity.
    J Neurochem. 2005 Apr;93(2):493-501 PMID: 15816872
  87. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis.
    PLoS Biol. 2005 Apr;3(4):e101 PMID: 15760270
  88. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.
    Mov Disord. 2005 Jun;20(6):674-9 PMID: 15704211
  89. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.
    Neuron. 2005 Jul 7;47(1):29-41 PMID: 15996546
  90. Metabolic control through the PGC-1 family of transcription coactivators.
    Cell Metab. 2005 Jun;1(6):361-70 PMID: 16054085
  91. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.
    J Biol Chem. 2005 Sep 2;280(35):30773-82 PMID: 15983033
  92. Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways.
    Hum Mol Genet. 2005 Oct 1;14(19):2893-909 PMID: 16115810
  93. Dnm1 forms spirals that are structurally tailored to fit mitochondria.
    J Cell Biol. 2005 Sep 26;170(7):1021-7 PMID: 16186251
  94. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.
    J Neurochem. 2005 Oct;95(2):553-62 PMID: 16135087
  95. Huntingtin associates with acidic phospholipids at the plasma membrane.
    J Biol Chem. 2005 Oct 28;280(43):36464-73 PMID: 16085648
  96. The axonal transport of mitochondria.
    J Cell Sci. 2005 Dec 1;118(Pt 23):5411-9 PMID: 16306220
  97. Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP.
    J Cell Biol. 2005 Dec 19;171(6):925-30 PMID: 16344307
  98. Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation.
    Mech Ageing Dev. 2006 Feb;127(2):217-20 PMID: 16289240
  99. Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons.
    J Biol Chem. 2006 Feb 10;281(6):3552-9 PMID: 16339760
  100. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
    Mol Biol Cell. 2006 Apr;17(4):1652-63 PMID: 16452635
  101. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.
    Neurobiol Dis. 2006 May;22(2):388-400 PMID: 16473015
  102. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.
    Cell. 2006 Jun 16;125(6):1179-91 PMID: 16777606
  103. Mitochondria: dynamic organelles in disease, aging, and development.
    Cell. 2006 Jun 30;125(7):1241-52 PMID: 16814712
  104. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
    Cell. 2006 Oct 6;127(1):59-69 PMID: 17018277
  105. Mitochondrial fusion and fission in mammals.
    Annu Rev Cell Dev Biol. 2006;22:79-99 PMID: 16704336
  106. Tissue heterogeneity of the mammalian mitochondrial proteome.
    Am J Physiol Cell Physiol. 2007 Feb;292(2):C689-97 PMID: 16928776
  107. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
    Nat Neurosci. 2002 Aug;5(8):731-6 PMID: 12089530
  108. Weight loss in early stage of Huntington's disease.
    Neurology. 2002 Nov 12;59(9):1325-30 PMID: 12427878
  109. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis.
    J Cell Biol. 2002 Dec 23;159(6):931-8 PMID: 12499352
  110. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development.
    J Cell Biol. 2003 Jan 20;160(2):189-200 PMID: 12527753
  111. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.
    Endocr Rev. 2003 Feb;24(1):78-90 PMID: 12588810
  112. Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice.
    Hum Mol Genet. 2003 Mar 1;12(5):497-508 PMID: 12588797
  113. The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor.
    BMC Neurosci. 2002 Oct 14;3:15 PMID: 12379151
  114. Transcriptional abnormalities in Huntington disease.
    Trends Genet. 2003 May;19(5):233-8 PMID: 12711212
  115. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition.
    J Neurosci. 2003 Jun 15;23(12):4858-67 PMID: 12832508
  116. The hunt for huntingtin function: interaction partners tell many different stories.
    Trends Biochem Sci. 2003 Aug;28(8):425-33 PMID: 12932731
  117. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
    Nat Genet. 2003 Sep;35(1):76-83 PMID: 12881722
  118. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.
    Neuron. 2003 Sep 25;40(1):25-40 PMID: 14527431
Article Info
Journal
Trends in neurosciences
Abbr.
Trends Neurosci
ISSN
0166-2236
Published
2008-12-00
Epub
2008-00-24
Pages
609-16
Language
English
Region
England
NLM ID
7808616
PMCID
PMC2613540
Subset
IM
Grants
NINDS NIH HHS · R01 NS047456-03S1 · United States
NINDS NIH HHS · R01 NS047456-01 · United States
NINDS NIH HHS · R01 NS055193 · United States
NEI NIH HHS · R01 EY016164-03 · United States
NINDS NIH HHS · R01 NS047456-02 · United States
NEI NIH HHS · R01 EY016164 · United States
NINDS NIH HHS · R01 NS047456-01S1 · United States
NINDS NIH HHS · R01 NS047456-05 · United States
NINDS NIH HHS · R01 NS055193-01A2 · United States
NEI NIH HHS · R01 EY016164-04 · United States
NINDS NIH HHS · R01 NS047456-04 · United States
NEI NIH HHS · R01 EY016164-02 · United States
NINDS NIH HHS · R01 NS047456 · United States
NINDS NIH HHS · R01 NS047456-03 · United States
NEI NIH HHS · R01 EY016164-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com